Is TMEM237 p.Pro61= (c.183C>T) pathogenic?

TMEM237 p.Pro61= (c.183C>T) is classified Conflicting classifications of pathogenicity in TMEM237 (ClinVar, Conflicting submitters, 5 submitters; last evaluated 2026-01-19). Rare (popmax 0.149%, mid); Associated with Joubert syndrome 14.

What condition is associated with TMEM237 p.Pro61= (c.183C>T)?

TMEM237 p.Pro61= (c.183C>T) is associated with Joubert syndrome 14 (ClinVar).

How common is TMEM237 p.Pro61= (c.183C>T) in the general population?

TMEM237 p.Pro61= (c.183C>T) is rare (popmax 0.149%, mid) (gnomAD).

TMEM237 p.Pro61=

c.183C>T · rs372100073 · VCV783168

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 5 submitters

gnomAD v4.1

Rare

rare (popmax 0.149%, mid)

Conditions

Joubert syndrome 14

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -3.4	GERP -5.1
Overall
CADD	1.574	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.149% Middle Eastern · 9/6,038 alleles

Filtering AF 0.0777% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.058%

Overall 0.02% 322/1,606,800 alleles · rare

Ancestry group	Frequency	1 in
Amishnot grpmax-eligible	0.548%	182
Middle Easterngrpmax	0.149%	671
Ashkenazi Jewishnot grpmax-eligible	0.0852%	1,174
Remaining individualsnot grpmax-eligible	0.0402%	2,491
Admixed American	0.0372%	2,688
European (non-Finnish)	0.0194%	5,162
South Asian	0.00672%	14,881
African / African-American	0.00267%	37,433

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: TMEM237
Protein: p.Pro61=
Coding: c.183C>T
MANE Select: NM_001044385
dbSNP: rs372100073
Type: single nucleotide variant
Location: chr2:201636839 (GRCh38)
Gene constraint: LOEUF 1.318 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 63.79
Residue 61: the 'disordered' region

Full TMEM237 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Joubert syndrome 14 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

TMEM237 c.136+1G>T Likely pathogenic ★★ same condition
TMEM237 c.553+1G>A Pathogenic/Likely pathogenic ★★ same condition
TMEM237 c.677+1G>A Pathogenic/Likely pathogenic ★★ same condition
TMEM237 c.869+1G>A Pathogenic/Likely pathogenic ★★ same condition
TMEM237 c.943+1G>T Pathogenic ★★ same condition
TMEM237 p.Arg109Ter Pathogenic ★★ same condition
TMEM237 p.Arg18Ter Pathogenic ★★ same condition
TMEM237 p.Arg301Ter Pathogenic/Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tmem237-p-pro61 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown